Patient Safety and Risk Management

PS-078

THERAPEUTIC EDUCATION OF THE PATIENT: THE ROLE OF THE HOSPITAL PHARMACIST

PS-077

DOSE OPTIMISATION OF OMALIZUMAB IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA

PS-072

DOES THE COMPUTERISED PHYSICIAN ORDER ENTRY SYSTEM REDUCE PRESCRIBING ERRORS FOR INPATIENTS? A BEFORE AND AFTER STUDY

PS-070

EVALUATION OF A PROGRAMME OF MEDICATION RECONCILIATION AT HOSPITAL ADMISSION IN TRAUMA PATIENTS REQUIRING SURGERY

PS-069

EVALUATION OF POST-CHEMOTHERAPY TOXICITIES IN CANCER PATIENTS WHO ATTENDED THE EMERGENCY SERVICE

PS-068

EVALUATION OF THE INCIDENCE AND THE CONSEQUENCES OF THE EXTRAVASATION OF CHEMOTHERAPY DRUGS IN A TERTIARY HOSPITAL

PS-067

INAPPROPRIATE USE OF PROTON PUMP INHIBITORS AMONG ELDERLY PEOPLE: AUDIT IN A GERIATRIC HOSPITAL

PS-066

INFUSION REACTIONS DOCUMENTED WITH DIFFERENT GENERIC PACLITAXEL FORMULATIONS BY MEANS OF AN ADVERSE DRUG REACTIONS REPORTING PROGRAMME

PS-065

IVABRADINE PRESCRIPTION ACCORDING TO PHARMACOVIGILANCE RISK ASSESSMENT COMMITTEE RESTRICTIONS

PS-064

MEDICATION ERRORS IN AN EMERGENCY DEPARTMENT OBSERVATION UNIT

PS-063

MEDICATION LABEL DESIGN AND PATIENT SAFETY: AN INTERACTIVE COMPARISON TEST

PS-062

DESENSITISATION PROTOCOL FOR CABAZITAXEL: A CASE REPORT

PS-058

ANALYSIS OF PHARMACEUTICAL INTERVENTIONS IN THE ONCO-HAEMATOLOGY AREA IN A TERTIARY LEVEL HOSPITAL

PS-056

PRIORITISATION OF PATIENTS FOR MEDICATION RECONCILIATION: APPLICATION IN PATIENTS HOSPITALISED IN THE EMERGENCY UNIT

PS-054

USE OF CONTRAINDICATED DRUGS IN PARKINSON’S DISEASE PATIENTS

Pages